Chemical Structure 37.1
Cocaine (benzoylmethylecgonine)
Chemical Structure 37.2
Methamphetamine (N-methylamphetamine)
Chemical Structure 37.3
MDMA (3,4-methylenedioxy-N-methylamphetamine)
Chemical Structure 37.4
Heroin (diacetylmorphine or morphine diacetate)
References
1.
Katzung BG. “Drugs of abuse”. Basic and clinical pharmacology. 10th ed. New York: McGraw-Hill companies; 2007. p. 518–23.
2.
US Department of Health and Human Services. National survey on drug use and health. Washington, DC: US Department of Health and Human Services; 2008.
3.
Brookoff D, Campbell EA, Shaw LM. The underreporting of cocaine-related trauma: drug abuse warning network reports vs hospital toxicology tests. Am J Public Health. 1993;83(3):369–71.PubMedCentralPubMed
5.
Hertting G, Axelrod J, Whitby LG. Effect of drugs on the uptake and metabolism of H3-norepinephrine. J Pharmacol Exp Ther. 1961;134:146–53.
6.
Kaye AD, Weinkauf JL. The cocaine addicted patient. In: Bryson EO, Frost EAM, editors. Perioperative addiction. New York: Springer Science and Business Media; 2011.
7.
Wang Z, Fermini B, Nattel S. Mechanism of flecainide’s rate-dependent actions on action potential duration in canine atrial tissue. J Pharmacol Exp Ther. 1993;267:575–81.PubMed
8.
Bauman JL, Grawe JJ, Winecoff AP, Hariman RJ. Cocaine-related sudden cardiac death: a hypothesis correlating basic science and clinical observations. J Clin Pharmacol. 1994;34:902–11.PubMed
9.
Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol. 2007;100(6):1040–3.PubMed
10.
Lucena J, Blanco M, Jurado C, Rico A, Salguero M, Vazquez R, Thiene G, Basso C. Cocaine-related sudden death: a prospective investigation in south-west Spain. Eur Heart J. 2010;31(3):318–29.PubMed
11.
Heesch CM, Negus BH, Steiner M. Effects of in vivo cocaine administration on human platelet aggregation. Am J Cardiol. 1996;78:237–9.PubMed
12.
Yu Q, Montes S, Larson D, Watson RR. Effects of chronic methamphetamine exposure on heart function in uninfected and retrovirus-infected mice. Life Sci. 1995;75:29–43.
13.
National Institute on Drug Abuse. Methamphetamine abuse and addiction: what is methamphetamine? Bethesda: National Institute of Health; 1998. NIDA research report series, NIH publication 98-4210.
14.
Volkow ND, Chang L, Wang GJ, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry. 2001;158(3):377–82.PubMed
15.
Bryson EO. Spotlight on methamphetamine. In: Bryson EO, Frost EAM, editors. Perioperative addiction. New York: Springer Science and Business Media; 2011.
16.
Karch SB, Stephens BG, Ho CH. Methamphetamine related deaths in San Francisco; demographic, pathologic and toxicologic profiles. J Forensic Sci. 1999;44:359–68.PubMed
17.
Suarez RV, Riemersma R. “Ecstasy” and sudden cardiac death. Am J Forensic Med Pathol. 1988;9:339–41.PubMed
18.
Shulgin AT. The background and chemistry of MDMA. J Psychoactive Drugs. 1986;18:291–304.PubMed
Related posts:
Antihypertensives, Diuretics, and Antidysrhythmics
Benzodiazepines and Muscle Relaxants
Hormones Part 2: Insulin and Other Glucose-Controlling Medications
Novel Psychoactive Substances: Synthetic Cathinones and Cannabinoid Receptor Agonists
New Vistas in Anesthetics, IV Induction Agents
Central Nervous System Stimulants
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
